Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Autocrine interleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis.

Blood - 15 Jan 2001

Frassanito M A, Cusmai A, Iodice G, Dammacco F

Abstract excerpt

In this study, flow cytometry was used to evaluate interleukin-6 (IL-6) production by bone marrow mononuclear cells from 47 patients with multiple myeloma (MM) in different clinical stages and 15 patients with monoclonal gammopathy of undetermined significance. In patients with MM, autocrine IL-6 production paralleled the clinical disease stage. The largest proportion of syndecan-1(+)/IL-6(+) cells was detected...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autocrine Communication
Share to Bone Marrow Cells
Share to Cell Culture Techniques

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Multiple Myeloma

Share to Paraproteinemias

Share to Proteoglycans

Share to Statistics, Nonparametric

Share to Syndecan-1

Source

Identifiers

PMID: 11154226
DOI: 10.1182/blood.v97.2.483

Genes

MCC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Autocrine interleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis.PMID 11154226Read ↗

Mcl‐1 and Bcl‐x<sub>L </sub> are co‐regulated by IL‐6 in human myeloma cellsSemantic proximity Read ↗

Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation.Semantic proximity Read ↗

Effects of IL-6 variants in multiple myeloma: growth inhibition and induction of apoptosis in primary cells.Semantic proximity Read ↗

New insights in the clinical biology of multiple myeloma.Semantic proximity Read ↗

Activating mutations in STAT3 and STAT5 differentially affect cellular proliferation and apoptotic resistance in multiple myeloma cells.Semantic proximity Read ↗

The effect of azacitidine on interleukin-6 signaling and nuclear factor- B activation and its in vitro and in vivo activity against multiple myelomaSemantic proximity Read ↗

[Advances in the pathogenesis, biology, and management of multiple myeloma].Semantic proximity Read ↗

The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptorSemantic proximity Read ↗

Role of interleukin 6 in the growth of myeloma-derived cell lines.Semantic proximity Read ↗

The bone marrow stromal microenvironment influences myeloma therapeutic response in vitro.Semantic proximity Read ↗

Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266Semantic proximity Read ↗

A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.